AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Resmed DRC

31.900

-0.100-0.31%

Volume:1.22M

Turnover:38.77M

Market Cap:46.50B

PE:2.13

High:31.900

Open:31.790

Low:31.530

Close:32.000

52wk High:42.833

52wk Low:25.425

Shares:1.46B

Float Shares:145.49M

Volume Ratio:1.56

T/O Rate:0.84%

Dividend:0.35

Dividend Rate:1.09%

EPS(TTM):14.980

EPS(LYR):14.980

ROE:24.27%

ROA:14.00%

PB:4.92

PE(LYR):2.13

Loading ...

Overview Company News Filings

ResMed's $490 Million Sale of MatrixCare Not Material to Outlook, RBC Says

MT Newswires Live

Resmed is Maintained at Equal-weight by Wells Fargo

Resmed Bull Sees Divestment Sharpening Strategic Focus

Resmed's Matrixcare Sale May Hint at AI Disruption Risk

Resmed Sees 3Q Closing for Matrixcare Divestiture

Palantir, WPC, Resmed, Figma, Leidos Trending With Analysts

ResMed Loses Bull as Margin Outlook Moderates -- Market Talk

Undervalued ASX healthcare provider

Morning Star AU

Australian shares inch lower, hurt by banks and energy; miners limit losses

How ResMed–Oura Wearable Sleep Data Partnership Could Reshape ResMed's (RMD) Clinical Ecosystem

Simply Wall St.

Australia R&D Changes Look Positive for CSL, Others -- Market Talk

A Look At ResMed (RMD) Valuation After Strong Earnings And CFO Transition

Simply Wall St.

Medical Device Makers Best Placed to Mitigate Higher Oil Costs -- Market Talk

Market Chatter: CSL, Resmed, Cochlear Lead Losses on ASX

MT Newswires Live

Analysts Are Bullish on Top Healthcare Stocks: Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD), First Tracks Biotherapeutics Inc (TRAX)

ResMed on Track for Lowest Close Since July 2024 -- Data Talk

ResMed Is Maintained at Equal-Weight by Wells Fargo

ResMed Bull Seems Happy With 3Q Performance -- Market Talk

Press Release: Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/RMD.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RMD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","market":"AU","secType":"STK","nameCN":"Resmed DRC","latestPrice":31.9,"timestamp":1791349920000,"preClose":32,"halted":0,"volume":1219169,"delay":0,"changeRate":-0.0031250000000000444,"nameEN":"Resmed DRC","floatShares":145494856,"shares":1457529700,"eps":14.979691961233764,"marketStatus":"Not Yet Opened","change":-0.1,"latestTime":"10-07 16:12:00 AEDT","open":31.79,"high":31.9,"low":31.53,"amount":38768410,"amplitude":0.011562,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":14.979691961233764,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791414000000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"ASX","adjPreClose":32,"dividendRate":0.0109,"openAndCloseTimeList":[[1791327600000,1791349200000]],"volumeRatio":1.5579749590727807,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RMD.AU","preClose":31.9,"auctionPrice":31.9,"auctionVolume":178,"auctionTime":1791407197998,"referenceTime":1791369003092,"auction":1,"marketStatus":"盘前竞价","timestamp":1791407197998}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","floatShares":145494856,"roa":"14.00%","roe":"24.27%","lyrEps":14.979692,"volumeRatio":1.5579749590727807,"shares":1457529700,"dividePrice":0.3477,"high":31.9,"amplitude":0.011562,"preClose":32,"low":31.53,"week52Low":25.425,"pbRate":"4.92","psRate":"5.73","week52High":42.833,"institutionHeld":0,"latestPrice":31.9,"eps":14.979691961233764,"divideRate":0.0109,"volume":1219169,"delay":0,"ttmEps":14.979691961233764,"open":31.79,"prevYearClose":35.646,"prevWeekClose":31.79,"prevMonthClose":31.98,"prevQuarterClose":31.98,"fiveDayClose":31.98,"twentyDayClose":30.74,"sixtyDayClose":27.658,"earningDate":1793289600000,"dividendPayoutRate":0.02326337710008864,"dividendGrowthYears":2,"dividendGrowthRate":0.076841184280566,"fiveYearAvgDividendRate":0.01298073865708731},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RMD.AU\",params:#limit:5,,,undefined,":[{"date":"2026-10-30","symbol":"RMD.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1793314800000,"name":null,"time":"","dateTimestamp":1793278800000,"actualEps":null},{"date":"2026-08-19","symbol":"RMD.AU","amount":0.066,"announcedDate":"2026-08-07","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-08-20","defaultRemindTime":1787097600000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-24","payableDate":"2026-08-20","currency":"USD","dateTimestamp":1787061600000,"payDate":"2026-09-24"},{"market":"AU","date":"2026-08-07","symbol":"RMD.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1786024800000,"reportTimeType":"","actualEps":null},{"date":"2026-05-13","symbol":"RMD.AU","amount":0.06,"announcedDate":"2026-05-01","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-05-14","defaultRemindTime":1778630400000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-05-14","currency":"USD","dateTimestamp":1778594400000,"payDate":"2026-06-18"},{"market":"AU","date":"2026-05-01","symbol":"RMD.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777557600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RMD.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-08-19","recordDate":"2020-08-20","paymentDate":"2020-09-24","value":0.039,"currency":"USD"},{"executeDate":"2020-11-11","recordDate":"2020-11-12","paymentDate":"2020-12-17","value":0.039,"currency":"USD"},{"executeDate":"2021-02-10","recordDate":"2021-02-11","paymentDate":"2021-03-18","value":0.039,"currency":"USD"},{"executeDate":"2021-05-12","recordDate":"2021-05-13","paymentDate":"2021-06-17","value":0.039,"currency":"USD"},{"executeDate":"2021-08-18","recordDate":"2021-08-19","paymentDate":"2021-09-23","value":0.042,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RMD.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649733992","title":"ResMed's $490 Million Sale of MatrixCare Not Material to Outlook, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2649733992","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649733992?lang=en_us&edition=fundamental","pubTime":"2026-07-08 23:38","pubTimestamp":1783525109,"startTime":"0","endTime":"0","summary":"ResMed  is selling its MatrixCare business for a \"cheap\" price of $490 million, but the transaction is not material to the company's outlook, RBC Capital Markets said in a note Wednesday.The brokerage said that while it was unlikely that MatrixCare would be sold at the 25x EV/EBITDA multiple at which it was acquired in 2018, a low double-digit to mid-teens multiple might have been achievable, compared with the 8.4x multiple at which it was sold.The low multiple at which MatrixCare was sold raises questions about future artificial intelligence disruptions to ResMed's software business, according to the note.The transaction did not surprise, though, as MatrixCare was detracting from the overall growth of ResMed's residential care software segment, the brokerage said.RBC retained an outperform rating on the stock, but lowered its price target to $276 from $321.Shares of ResMed were down 4.9% in Wednesday trading.Price: 209.08, Change: -10.67, Percent Change: -4.86","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B5TLWC47.USD","RMD.AU","BK4082","LU2177674079.SGD","LGHT","LU2008162690.USD","LU0170899867.USD","BK4548","BK4588","BK4504","BK4567","BK7007","BK7501","BK4585","RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649960493","title":"Resmed is Maintained at Equal-weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2649960493","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649960493?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:50","pubTimestamp":1783507800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RMD/analyst-ratings(END) Dow Jones NewswiresJuly 08, 2026 06:50 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314106906.USD","PGF","LU0868494708.USD","LU1074936037.SGD","LU0208291251.USD","LU2008162690.USD","FTXO","BK7007","LU1069347547.HKD","RMD.AU","IE0002270589.USD","LU2361044865.SGD","LU0310800965.SGD","KBWB","LU0310800379.SGD","RMD","BK4567","LU1668664300.SGD","LU0154236417.USD","IE00B7SZLL34.SGD","LU0310799852.SGD","LU1280957306.USD","LU1814569148.SGD","LU1267930227.SGD","LU1035773651.USD","LU0162691827.USD","BK7501","LU1267930573.SGD","IE00B19Z3581.USD","LU0211327993.USD","LU0648001328.SGD","LU0742534661.SGD","IE00B19Z3B42.SGD","LU0267386448.USD","LU0128525689.USD","IE000M9KFDE8.USD","LU1894683348.USD","LU0170899867.USD","LU0417517546.SGD","LU0251142724.SGD","LU0980610538.SGD","LU0070302665.USD","IYF","LGHT","LU0942090050.USD","LU0048573561.USD","BK4559","LU1363072403.SGD","LU0072461881.USD","LU1201861249.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649576449","title":"Resmed Bull Sees Divestment Sharpening Strategic Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2649576449","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649576449?lang=en_us&edition=fundamental","pubTime":"2026-07-08 12:35","pubTimestamp":1783485300,"startTime":"0","endTime":"0","summary":"0435 GMT - ResMed's bull at Morgans likes the divestment of its MatrixCare division for the way it sharpens the breath-tech provider's strategic focus. Analyst Derek Jellinek explains in a note that the US$490 million sale simplifies the investment case for dual-listed ResMed by exiting the somewhat peripheral vertical of aged care, and increasing its exposure to core franchises including sleep devices and masks. The divestment monetizes a mature asset and funds shareholder returns that should help support ResMed's share price, Jellinek tells clients. Morgans has a buy rating on ResMed's Australia-listed stock and a target price of 41.72 Australian dollars. Shares are down 0.3% at A$31.345.  Dow Jones NewswiresJuly 08, 2026 00:35 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2177674079.SGD","BK4567","BK4548","LU2008162690.USD","RMD","BK4504","BK7007","IE00B5TLWC47.USD","LU0170899867.USD","RMD.AU","BK4588","LGHT","BK7501","BK4082","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649952059","title":"Resmed's Matrixcare Sale May Hint at AI Disruption Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2649952059","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649952059?lang=en_us&edition=fundamental","pubTime":"2026-07-08 12:09","pubTimestamp":1783483740,"startTime":"0","endTime":"0","summary":"0409 GMT - ResMed's sale of its MatrixCare business at a lower-than-expected earnings multiple leads RBC analyst Craig Wong-Pan to suspect that the breath-tech maker may have been worried about AI disruption risks. Wong-Pan didn't expect a sale to match the 25X earnings ResMed paid in 2018, but had anticipated a multiple in the low double digits to mid teens. Instead, ResMed is selling at 8.9X earnings. He expects the majority of the US$490 million proceeds to be distributed to shareholders. \"We wonder if ResMed's decision to sell at this multiple partly reflects possible risks of future AI disruption to its software business.\" RBC has an outperform rating and US$321.00 target price on ResMed's U.S.-listed stock. Its ASX-listed shares are down 0.5% at 31.29 Australian dollars.  Dow Jones NewswiresJuly 08, 2026 00:09 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTHR","RMD","LU2177674079.SGD","BK4567","BK4588","CHAT","BK4548","RMD.AU","BK7007","LGHT","BK4585","AIPO","LU0170899867.USD","QTOC","IE00B5TLWC47.USD","BK7501","AGIX","LU2008162690.USD","BK4504","ARTY","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649958992","title":"Resmed Sees 3Q Closing for Matrixcare Divestiture","url":"https://stock-news.laohu8.com/highlight/detail?id=2649958992","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649958992?lang=en_us&edition=fundamental","pubTime":"2026-07-08 05:27","pubTimestamp":1783459620,"startTime":"0","endTime":"0","summary":"Resmed's divestiture hands off the EHR software business MatrixCare to Frazier Healthcare Partners, a private equity firm focused exclusively on healthcare. Resmed CEO Mick Farrell said the company views Frazier as a suitable steward for MatrixCare's team and solutions. The transaction, expected to close in the third quarter, includes MatrixCare's related software offerings sold under the MatrixCare brand, including Healthcare First, Citus, and home health and hospice solutions. The companies did not disclose the terms of the deal.This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors. Dow Jones NewswiresJuly 07, 2026 17:27 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2177674079.SGD","LGHT","IE00B5TLWC47.USD","BK4548","BK4567","BK7007","RMD","BK4588","LU2008162690.USD","BK4585","LU0170899867.USD","RMD.AU","BK4504","BK4082","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644306714","title":"Palantir, WPC, Resmed, Figma, Leidos Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2644306714","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644306714?lang=en_us&edition=fundamental","pubTime":"2026-06-20 17:02","pubTimestamp":1781946149,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($PLTR) ), ( ($WPC) ), ( ($RMD) ), ( ($FIG) ) and ( ($LDOS) ). Here is a breakdown of their recent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/palantir-wpc-resmed-figma-leidos-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/palantir-wpc-resmed-figma-leidos-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLTG","RMD.AU","PTIR","IE00BZ9MQY76.HKD","PLTI","BK4588","PLTZ","PLTA","BK4613","PLOO","PLTU","BK7007","WPC","BK4585","IE00B19Z9P08.USD","BK4547","PLTD","IE00B19Z9Z06.USD","LU1861559042.SGD","LU1861558580.USD","PLTY","FIG","PLT","LDOS","LU0006061336.USD","BK4123","PLTW","BK4160","FIGG","PLYY","BK4543","BK7501","BK4023","IE00B894F039.SGD","PLTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644758057","title":"ResMed Loses Bull as Margin Outlook Moderates -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2644758057","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644758057?lang=en_us&edition=fundamental","pubTime":"2026-06-18 09:40","pubTimestamp":1781746800,"startTime":"0","endTime":"0","summary":"0140 GMT - ResMed loses its bull at Morgan Stanley, where analyst David L. Bailey reassesses his margin assumptions. Lowering his recommendation on the breath-tech provider to equal-weight from overweight, Bailey says that recent commentary from key component suppliers has highlighted pricing increases. He tells clients in a note that currency moves are also likely to be a near-term headwind. Price increases and operational efficiencies are seen as potential offsets, but his forecast for flat FY 2027 gross margins sits slightly below consensus. MS lowers its target price on dual-listed ResMed's U.S. stock by 20% to US$230.00. Shares closed at US$186.29. ResMed's Australia-listed stock is down 3.5% at 26.585 Australian dollars. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875169.SGD","LU1732800096.USD","LU0106261372.USD","LU2264538146.SGD","LU1989772923.USD","LU0006306889.USD","LU2089284900.SGD","LU1244550221.USD","LU1548497426.USD","LU0106831901.USD","LU2133065610.SGD","LU2271345857.HKD","LU1988902786.USD","LU1720051017.SGD","LU1791710582.SGD","BK4567","LU2177674079.SGD","BK7501","LU0225283273.USD","LU0320765646.SGD","LU1668664300.SGD","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU0912757837.SGD","RMD","BK4516","LU1363072403.SGD","LU2357305700.SGD","RMD.AU","LU0557290698.USD","LU0210528500.USD","LU1064131342.USD","LU2111349929.HKD","LU2347655156.SGD","BK4548","BK4082","LU0882574139.USD","LU1732799900.SGD","LU2487616109.SGD","LU1162221912.USD","LU2089283258.USD","LU0234570918.USD","IE00B5TLWC47.USD","BK7007","LU0267386448.USD","LU1244550577.SGD","BK4581","BK4585","LU0170899867.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640918762","title":"Undervalued ASX healthcare provider","url":"https://stock-news.laohu8.com/highlight/detail?id=2640918762","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640918762?lang=en_us&edition=fundamental","pubTime":"2026-06-02 00:00","pubTimestamp":1780329600,"startTime":"0","endTime":"0","summary":"We transfer coverage of ResMed (ASX: RMD), one of the largest respiratory care device companies globally. It primarily sells flow generators and masks for the treatment of sleep apnea. Demand is under","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/undervalued-asx-healthcare-provider","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/undervalued-asx-healthcare-provider","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["IXJ","BK4588","RMD.AU","BK4550","VHT","BK7501","BK4585","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640398285","title":"Australian shares inch lower, hurt by banks and energy; miners limit losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2640398285","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640398285?lang=en_us&edition=fundamental","pubTime":"2026-06-01 09:47","pubTimestamp":1780278450,"startTime":"0","endTime":"0","summary":"Australian shares inch lower, hurt by banks and energy; miners limit losses June 1 (Reuters) - Australian shares edged lower on Monday, weighed down by banks, healthcare, and energy stocks, though gai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nL4N42803O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STO.AU","XRO.AU","YAL.AU","BK7507","BK7007","BK7104","BK7506","WHC.AU","EVN.AU","WDS.AU","BK7501","BK7095","RMD.AU","BK7142","BK7509","BK7503","BK7083","WTC.AU","BHP.AU","RIO.AU","BK7016","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637987360","title":"How ResMed–Oura Wearable Sleep Data Partnership Could Reshape ResMed's (RMD) Clinical Ecosystem","url":"https://stock-news.laohu8.com/highlight/detail?id=2637987360","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637987360?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:35","pubTimestamp":1779420940,"startTime":"0","endTime":"0","summary":"On 19 May 2026, ResMed and Oura announced a partnership that connects Oura Ring Gen3 and Ring 4 members in the U.S. to ResMed’s sleep education tools, assessments, and options to link with independent healthcare providers.\nThis collaboration uniquely bridges consumer wearable sleep data with clinical sleep resources, aiming to help address undiagnosed conditions such as obstructive sleep apnea.\nNext, we’ll examine how integrating Oura’s consumer wearables data with ResMed’s clinical sleep...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/how-resmedoura-wearable-sleep-data-partnership-could-reshape","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/how-resmedoura-wearable-sleep-data-partnership-could-reshape","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4567","BK4548","LU0170899867.USD","BK4585","BK7007","RMD","BK4588","LU2177674079.SGD","IE00B5TLWC47.USD","LU2008162690.USD","RMD.AU","BK4082","BK4504","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635229966","title":"Australia R&D Changes Look Positive for CSL, Others -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635229966","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635229966?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:27","pubTimestamp":1778628420,"startTime":"0","endTime":"0","summary":"Australian government changes to R&D taxation look positive for locally listed medical manufacturers, RBC Capital Markets analyst Craig Wong-Pan says. The government is increasing the amount of R&D expenditure that companies can claim as a tax offset, while also lifting R&D disbursements paid out from the sovereign Medical Research Future Fund. Wong-Pan thinks this looks like good news for pharmaceutical manufacturer CSL, breath-tech maker ResMed, hearing-implant developer Cochlear and infection-prevention company Nanosonics. From July 2028, the tax offset for experimental core R&D will rise to 50%. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2177674079.SGD","LU1169590202.USD","BK4504","BK7511","COH.AU","BK7508","CSL","BK7501","IE00B5TLWC47.USD","BK4082","NAN.AU","RMD","BK4567","SG9999004303.SGD","BK7503","BK4588","LU2008162690.USD","BK7126","BK7067","LU1169589451.USD","CSL.AU","LU0170899867.USD","BK4585","BK4086","BK7007","BK4548","LU0728928796.USD","SGXZ23171101.USD","RMD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634406469","title":"A Look At ResMed (RMD) Valuation After Strong Earnings And CFO Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2634406469","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634406469?lang=en_us&edition=fundamental","pubTime":"2026-05-09 02:49","pubTimestamp":1778266197,"startTime":"0","endTime":"0","summary":"ResMed (RMD) recently combined a CFO transition with quarterly results that showed higher sales, net income and earnings per share year over year, a mix that tends to sharpen investor focus on the stock.\nSee our latest analysis for ResMed.\nEven with higher quarterly sales and earnings, ResMed’s recent share price has been under pressure, with a 30 day share price return of an 8.48% decline and a 90 day share price return of a 23.83% decline. The 1 year total shareholder return of a 14.31%...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/a-look-at-resmed-rmd-valuation-after-strong-earnings-and-cfo","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/a-look-at-resmed-rmd-valuation-after-strong-earnings-and-cfo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RMD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633749719","title":"Medical Device Makers Best Placed to Mitigate Higher Oil Costs -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2633749719","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633749719?lang=en_us&edition=fundamental","pubTime":"2026-05-06 10:16","pubTimestamp":1778033760,"startTime":"0","endTime":"0","summary":"0216 GMT - Medical device makers ResMed and Fisher & Paykel Healthcare are best placed among Australia-listed healthcare stocks to mitigate oil-related cost increases, Morgan Stanley analysts say. They tell clients in a note that high margins and pricing power are the best defense against the impact of cost increases thrust upon companies by the Iran conflict. The investment bank's analysts says that service providers such as Ramsay Health Care and Sonic Healthcare are likely to be hit harder due to their lower margins. Their pricing power is lower because they rely on government and health-insurance income, the analysts add. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","LU1668664300.SGD","RMD.AU","LU0528227936.USD","LU0267386448.USD","LU0882574139.USD","LU1363072403.SGD","LU1732799900.SGD","LU0314104364.USD","LU0971096721.USD","LU2089284900.SGD","LU2177674079.SGD","LU2347655156.SGD","LU2357305700.SGD","RHC.AU","BK7124","SHL.AU","BK4548","BK4581","LU1988902786.USD","LU2089283258.USD","LU0557290698.USD","BK4585","BK7113","LU0912757837.SGD","BK4567","LU1074936037.SGD","LU0158827948.USD","LU2028103732.USD","LU0106261372.USD","LU2271345857.HKD","LU1244550577.SGD","LU0234570918.USD","LU1244550221.USD","LU0225283273.USD","LU0795875169.SGD","LU0006306889.USD","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU1244550494.USD","RMD","BK4082","LU0106831901.USD","LU0158827781.USD","LU0098860793.USD","LU0795875086.SGD","LU1548497426.USD","LU1989772840.SGD","LU1791710582.SGD","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632987285","title":"Market Chatter: CSL, Resmed, Cochlear Lead Losses on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2632987285","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632987285?lang=en_us&edition=fundamental","pubTime":"2026-05-04 11:54","pubTimestamp":1777866873,"startTime":"0","endTime":"0","summary":"CSL  led losses on the Australian bourse so far this year at AU$23.2 billion, while ResMed  and Cochlear  followed with losses of AU$10.6 billion, the Australian Financial Review reported Monday, citing Global X ETFs.Negative performing companies on the S&P/ASX 200 index collectively wiped out over AU$217 billion, said Marc Jocum, senior product and investment strategist at Global X ETFs.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","CSL","BK7511","BK7007","DBB","BK7508","COH.AU","CSL.AU","LU1169589451.USD","LU0728928796.USD","LU1169590202.USD","BK7067","BK7501","RMD.AU","SGXZ23171101.USD","BK4086","SG9999004303.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632162047","title":"Analysts Are Bullish on Top Healthcare Stocks: Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD), First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632162047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632162047?lang=en_us&edition=fundamental","pubTime":"2026-05-02 17:03","pubTimestamp":1777712583,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Resmed Inc CHESS Depositary Interests on a ratio of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-aurmd-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-aurmd-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B5TLWC47.USD","BK4548","BK4504","LU0128526141.USD","LU2008162690.USD","BLSX","LABU","BK4581","BK4567","RMD.AU","BK4137","BK4585","BK4588","LU0170899867.USD","BK4139","BK4082","BLSG","LU2177674079.SGD","TRAX","XBI","LU0029874061.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632645482","title":"ResMed on Track for Lowest Close Since July 2024 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2632645482","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632645482?lang=en_us&edition=fundamental","pubTime":"2026-05-02 00:06","pubTimestamp":1777651560,"startTime":"0","endTime":"0","summary":"ResMed Inc.  is currently at $203.57, down $10.24 or 4.79%. --Would be lowest close since July 26, 2024, when it closed at $197.04. --On pace for largest percent decrease since Feb. 12, 2026, when it fell 5.35%. --Down 7.41% this week; worst weekly performance since the week ending March 13, 2026, when it fell 8.71%. --Down 31.54% from its all-time closing high of $297.36 on Sept. 8, 2021. --Down 30.69% from its 52-week closing high of $293.73 on Aug. 22, 2025. --Traded as low as $198.64; lowest intraday level since July 29, 2024, when it hit $198.60. --Down 7.1% at today's intraday low; largest intraday percent decrease since Dec. 1, 2025, when it fell as much as 7.12%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK7007","BK4588","LU2008162690.USD","LU2177674079.SGD","BK4567","BK4082","BK4585","BK4548","IE00B5TLWC47.USD","RMD","LU0170899867.USD","RMD.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632648310","title":"ResMed Is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2632648310","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632648310?lang=en_us&edition=fundamental","pubTime":"2026-05-01 22:23","pubTimestamp":1777645380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 01, 2026 10:23 ET (14:23 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","LU2177674079.SGD","IE00B5TLWC47.USD","BK4207","LU0648001328.SGD","LU0211327993.USD","LU0251131958.USD","LU1267930490.SGD","LU0052756011.USD","LU0048573561.USD","IE00B19Z3581.USD","BK7501","LU1506573853.SGD","LU2236285917.USD","LU2461242641.AUD","LU2361045086.USD","LU0742534661.SGD","BK4567","LU0417517546.SGD","RMD","LU0251142724.SGD","LU0149725797.USD","LU0256863811.USD","LU0289960550.SGD","LU2008162690.USD","LU0320765489.SGD","LU1668664300.SGD","RMD.AU","LU0640476718.USD","LU0708994859.HKD","BK7007","LU1267930227.SGD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU2361044865.SGD","IE0002270589.USD","LU0942090050.USD","LU1894683348.USD","BK4501","LU2361044949.HKD","BK4504","BK4559","LU0310800965.SGD","LU1267930573.SGD","LU0130102774.USD","LU0162691827.USD","LU0072461881.USD","BK4585","LU0787776722.HKD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632952716","title":"ResMed Bull Seems Happy With 3Q Performance -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2632952716","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632952716?lang=en_us&edition=fundamental","pubTime":"2026-05-01 09:12","pubTimestamp":1777597920,"startTime":"0","endTime":"0","summary":"0112 GMT - ResMed's 3Q result is greeted warmly by its bull at RBC Capital Markets. Analyst Craig Wong-Pan tells clients in a note that the breath-tech provider delivered a slight beat to his and consensus forecasts across a majority of metrics. He likes that gross margin continued to improve, beating consensus forecasts by 30 basis points. Less positively, he acknowledges that 5.9% Americas revenue growth from devices fell short of an average analyst forecast of 9.1%. The announcement that CFO Brett Sandercock is retiring may also hit sentiment, he adds. RBC has a last-published outperform rating and US$314.00 target price on ResMed's U.S.-listed stock, which closed at US$213.81. ResMed's Australia-listed stock is down 2.6% at A$29.00. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4082","BK4548","BK7007","LU2008162690.USD","IE00B5TLWC47.USD","BK4567","LU2177674079.SGD","RMD","BK4585","LU0170899867.USD","BK4588","RMD.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632566680","title":"Press Release: Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor","url":"https://stock-news.laohu8.com/highlight/detail?id=2632566680","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632566680?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:10","pubTimestamp":1777579800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April 30, 2026  -- Resmed , the leading health technology company focused on sleep, breathing and care delivered in the home, today announced that Brett Sandercock, Chief Financial Officer, plans to retire effective May 4, 2026. After conducting a comprehensive search, Aaron Bloomer has been appointed as his successor.\"I'm honored to join Resmed at such an exciting time in its journey,\" said Aaron Bloomer. \"Resmed's leadership in digital health and its vision to create a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home, resonates with me. I look forward to working with the team to build on its strong foundation and support continued","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B5TLWC47.USD","BK4082","LU0170899867.USD","LU2008162690.USD","LU2177674079.SGD","BK4588","BK7007","BK4504","BK7501","RMD","RMD.AU","BK4567","BK4548"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":39,"code":"91000000","status":"200"}]}}